Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...
A new paper in Rheumatology Advances in Practice indicates that TikTok videos about gout are commonly misleading, inconsistent, or inaccurate. The paper is titled "Gout, TikTok and misleading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback